As it is highly unlikely that ∼80% of all CD8+ T cells in the peripheral blood during primary SARS-CoV-2 infection were antigen specific (even if directed at several CD8+ T cell epitopes), this suggests that a high proportion of CD8+ T cells are activated via some “bystander” mechanism during acute/convalescent COVID-19. This evidence concerns the gene CD8A and COVID-19.